GABA A,slow: causes and consequences
Marco Capogna1, Robert A Pearce
1MRC Anatomical Neuropharmacology Unit, Mansfield Road, Oxford OX1 3TH, UK. marco.capogna@pharm.ox.ac.uk
Abstract:
GABA(A) receptors in the CNS mediate both fast synaptic and tonic inhibition. Over the past decade a phasic current with features intermediate between fast synaptic and tonic inhibition, termed GABA(A,slow), has received increasing attention. This has coincided with an ever-growing appreciation for GABAergic cell type diversity. Compared with classical fast synaptic inhibition, GABA(A,slow) is slower by an order of magnitude. In this review, we summarize recent studies that have enhanced our understanding of GABA(A,slow). These include the discovery of specialized interneuron types from which this current originates, the factors that could underlie its characteristically slow kinetics, its contribution to specific aspects of integrative function and network oscillations, and its potential usefulness as a novel drug target for modulating inhibitory synaptic transmission in the CNS.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
CNS Depressants: Barbiturates and Benzodiazepines
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Desensitization and Tachyphylaxis
Several...
Generalized Anxiety Disorder
Sedatives and Hypnotics Drugs: Barbiturates


